Clinical trial

Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

NCT00520676

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-10-01

PhasePHASE3

Study timeline

Study start (unknown)2007-10-01Date precision: month

Registry last updated2011-08-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small Cell Lung Cancerunresolved

Interventions

pemetrexedDRUG · verified · RxNorm: pemetrexed

docetaxelDRUG · verified · RxNorm: docetaxel

carboplatinDRUG · verified · RxNorm: carboplatin

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

SeoulSouth Korea1 BeijingChina1 ShanghaiChina1 São PauloBrazil1 TaichungTaiwan1 Mexico CityMexico1 TaoyuanTaiwan1 NanjingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00520676 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.